Metformin for Patients With Type 2 Diabetes and Chronic Kidney Disease

There are now 11 drug classes in addition to multiple insulin options from which to choose to treat patients presenting with new-onset type 2 diabetes (T2DM). In an era of individualizing glycemic target ranges using shared decision making, patients must choose among medication options based on their understanding of their own potential benefits and harms, costs, and impact of adverse effects on their quality of life.
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research